{"target_list": {"TWi Pharmaceuticals USA, Inc.": {"source_list": [{"holder": "1", "name": "安成國際藥業股份有限公司"}], "taxcode": "NA"}, "TWi Pharmaceuticals Europe Limited": {"source_list": [{"holder": "1", "name": "安成國際藥業股份有限公司"}], "taxcode": "NA"}, "海南益健醫藥有限公司": {"source_list": [{"holder": "1", "name": "海南華益泰康藥業有限公司"}], "taxcode": "NA"}, "TWi Pharmaceutical Ltd.": {"source_list": [{"holder": "1", "name": "安成國際藥業股份有限公司"}], "taxcode": "NA"}, "安成生物科技股份有限公司": {"source_list": [{"holder": "0.7307", "name": "安成國際藥業股份有限公司"}], "taxcode": "25147136"}, "安成國際藥業股份有限公司": {"source_list": [{"holder": "NA", "name": "Opulent Assets Holdings Ltd."}, {"holder": "NA", "name": "TWI Pharmaceuticals Holding, Inc."}], "taxcode": "16284926"}, "海南華益泰康藥業有限公司": {"source_list": [{"holder": "0.6558", "name": "TWi Pharmaceuticals Cayman Ltd."}], "taxcode": "NA"}, "TWi Pharmaceuticals Cayman Ltd.": {"source_list": [{"holder": "0.9988", "name": "TWi Pharmaceutical Ltd."}], "taxcode": "NA"}}, "company_list": [{"taxcode_source": "16284926", "target": "TWi Pharmaceutical Ltd.", "has_fine": false, "source": "安成國際藥業股份有限公司", "holder": "1", "taxcode_target": "NA"}, {"taxcode_source": "NA", "target": "TWi Pharmaceuticals Cayman Ltd.", "has_fine": false, "source": "TWi Pharmaceutical Ltd.", "holder": "0.9988", "taxcode_target": "NA"}, {"taxcode_source": "16284926", "target": "TWi Pharmaceuticals Europe Limited", "has_fine": false, "source": "安成國際藥業股份有限公司", "holder": "1", "taxcode_target": "NA"}, {"taxcode_source": "16284926", "target": "TWi Pharmaceuticals USA, Inc.", "has_fine": false, "source": "安成國際藥業股份有限公司", "holder": "1", "taxcode_target": "NA"}, {"taxcode_source": "16284926", "target": "安成生物科技股份有限公司", "has_fine": false, "source": "安成國際藥業股份有限公司", "holder": "0.7307", "taxcode_target": "25147136"}, {"taxcode_source": "NA", "target": "安成國際藥業股份有限公司", "has_fine": false, "source": "Opulent Assets Holdings Ltd.", "holder": "NA", "taxcode_target": "16284926"}, {"taxcode_source": "NA", "target": "安成國際藥業股份有限公司", "has_fine": false, "source": "TWI Pharmaceuticals Holding, Inc.", "holder": "NA", "taxcode_target": "16284926"}, {"taxcode_source": "NA", "target": "海南益健醫藥有限公司", "has_fine": false, "source": "海南華益泰康藥業有限公司", "holder": "1", "taxcode_target": "NA"}, {"taxcode_source": "NA", "target": "海南華益泰康藥業有限公司", "has_fine": false, "source": "TWi Pharmaceuticals Cayman Ltd.", "holder": "0.6558", "taxcode_target": "NA"}], "company_summery": {"has_fine": true, "fine_penalty_amount": 200000, "company_amount": 10, "group_name": "安成藥業", "fine_record_num": 1, "group_no": "G4180", "fine_company_amount": 1}, "fine_company_list": [{"penalty_amount": 200000, "fine_num": 1, "name": "安成國際藥業股份有限公司", "taxcode": "16284926"}]}